-transparent.png){kind=logo}
Growth-hormone (GH) responses to the alpha 2-adrenoceptor agonist clonidine were measured in 9 panic disorder patients, in 9 patients fulfilling DSM-III-R criteria for major depressive episode, and in 9 age- and sex-matched controls. GH responses to clonidine were not significantly different between the groups. The data do not agree with the assumption that blunted GH responses to clonidine represent a general feature of panic disorder or major depression.
Related Publications
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
January 1995,
European archives of psychiatry and clinical neuroscience,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
February 1988,
Psychiatry research,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
November 1993,
Biological psychiatry,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
September 1986,
Biological psychiatry,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
July 1988,
Biological psychiatry,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
November 1992,
Psychological medicine,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
January 2019,
Psychopathology,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
July 1994,
Biological psychiatry,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
October 2002,
European archives of psychiatry and clinical neuroscience,
H Gann, and
D Riemann, and
S Stoll, and
M Berger, and
W E Müller
April 1995,
The American journal of psychiatry,
